Conwood Medipharma Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 22-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 22-12-2024
- Company Age 17 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 35.66 Cr
as on 22-12-2024
- Revenue %
(FY 2020)
- Profit 97.44%
(FY 2020)
- Ebitda 93.54%
(FY 2020)
- Net Worth -0.14%
(FY 2020)
- Total Assets 7.72%
(FY 2020)
About Conwood Medipharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹35.66 Cr.
Sukhdev Kumar, Navdeep Kumar, Suman Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24233DL2007PTC167585
- Company No.
167585
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Aug 2007
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Conwood Medipharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sukhdev Kumar  | Director | 31-Aug-2007 | Current |
| Navdeep Kumar | Director | 12-Feb-2008 | Current |
| Suman Kumar | Director | 23-Aug-2019 | Current |
| Jasmin | Director | 23-Aug-2019 | Current |
Financial Performance of Conwood Medipharma.
Conwood Medipharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 97.44% increase in profit. The company's net worth dipped by a decrease of 0.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Conwood Medipharma?
In 2019, Conwood Medipharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Indo-Gulf Diagnostics And Research Centre Private LimitedActive 26 years 5 monthsSukhdev Kumar and Navdeep Kumar are mutual person
- Roselle Infrastructure Private LimitedActive 18 years 10 months
Sukhdev Kumar, Navdeep Kumar and 2 more are mutual person
- Vc Infracon Private LimitedActive 14 years 3 months
Sukhdev Kumar, Suman Kumar and 1 more are mutual person
- Ar Compusoft Private LimitedActive 18 years 10 months
Sukhdev Kumar, Suman Kumar and 1 more are mutual person
- Silversmith Infotech Private LimitedActive 15 years 4 months
Sukhdev Kumar, Navdeep Kumar and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Aug 2024 | ₹5.96 M | Open |
Others Creation Date: 11 Mar 2024 | ₹4.41 Cr | Open |
Others Creation Date: 09 Jun 2023 | ₹3.65 Cr | Open |
How Many Employees Work at Conwood Medipharma?
Unlock and access historical data on people associated with Conwood Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Conwood Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Conwood Medipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
